Aura Biosciences, Inc.
$6.52
The Read: Aura Biosciences' stock rallied over 17% on accelerated Phase 3 enrollment and positive formulation data in early 2026 but dropped over 30% after a dilutive $299M equity raise and CEO change overshadowed EPS in Q2.
Price
Overlays
Panel
AURA
Hover to view data
No Data